Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2017-03-10 | 2017-03-16 | 366 |
| APO-LATANOPROST | 50MCG | SOLUTION | Resolved | 2017-03-10 | 2020-02-13 | 363 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
| APO-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 351 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 345 |
| APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
| APO-IRBESARTAN | 300MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 339 |
| APO-IRBESARTAN | 150MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 336 |
| APO-IMIQUIMOD | 5% | CREAM | Resolved | 2017-03-10 | 2019-11-26 | 333 |
| APO-HYDROCHLOROTHIAZIDE | 100MG | TABLET | Resolved | 2017-03-10 | 2019-11-26 | 330 |
| APO-FUROSEMIDE | 80MG | TABLET | Resolved | 2017-03-10 | 2017-06-05 | 327 |
| APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-03-10 | 2017-04-10 | 324 |
| APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 318 |
| APO-EXEMESTANE | 25MG | TABLET | Resolved | 2017-03-10 | 2019-06-12 | 314 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-10-11 | 311 |
| APO-ELETRIPTAN | 40MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 308 |
| APO-ELETRIPTAN | 20MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 305 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION | Resolved | 2017-03-10 | 2019-07-13 | 290 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-03-10 | 2018-12-18 | 287 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-03-10 | 2018-12-18 | 284 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
| APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
| APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-FUROSEMIDE | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
| APO-FUROSEMIDE | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-11-16 | 60474 |
| APO-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60471 |
| APO-ENALAPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60468 |
| APO-ENALAPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-19 | 60465 |
| APO-ENALAPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-12-05 | 60462 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-29 | 60459 |